Thompson Investment Management, Inc.
Source: SEC Form 13F · as of Mar 2026Thompson Investment Management, Inc. holds 27 biotech & pharma companies tracked by BioSniper, totaling $85.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
27
Total value held
$85.8M
| Company | Shares | Value |
|---|---|---|
| VTRSViatris Inc | 1,105,192 | $14.9M |
| PFEPFIZER INC | 464,171 | $13.0M |
| JNJJOHNSON & JOHNSON | 48,730 | $11.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 42,295 | $11.4M |
| ABBVAbbVie Inc. | 31,807 | $6.9M |
| BMYBRISTOL MYERS SQUIBB CO | 105,214 | $6.4M |
| AMGNAMGEN INC | 17,837 | $6.3M |
| GEHCGE HealthCare Technologies Inc. | 59,798 | $4.3M |
| MCKMcKesson Corporation | 4,758 | $4.1M |
| MRKMerck & Co., Inc. | 24,453 | $2.9M |
| NBIXNEUROCRINE BIOSCIENCES INC | 9,755 | $1.3M |
| JAZZJazz Pharmaceuticals plc | 5,765 | $1.1M |
| IDXXIDEXX LABORATORIES INC /DE | 750 | $421K |
| PMPhilip Morris International Inc | 1,867 | $309K |
| ABTABBOTT LABORATORIES | 1,587 | $163K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 1,636 | $90K |
| GMOptec International, Inc. | 1,164 | $87K |
| AZNASTRAZENECA PLC | 313 | $62K |
| MDXGMiMedx Group Inc | 13,200 | $52K |
| LLYELI LILLY & Co | 25 | $23K |
| BAXBaxter International Inc. | 964 | $16K |
| NVSNovartis AG | 31 | $5K |
| ZBHZimmer Biomet Holdings Inc. | 35 | $3K |
| ARDXARDELYX, INC. | 185 | $1K |
| CRLBFCresco Labs Inc. | 725 | $631 |
| OGNOrganon & Co. | 82 | $491 |
| INOINOVIO PHARMACEUTICALS, INC. | 13 | $23 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.